Treatment impact of newly approved therapeutic agents for metastatic urothelial carcinoma in Japan: a single-center retrospective study

Although recent clinical trials of new therapeutic agents for metastatic urothelial carcinoma have shown prolonged overall survival, there are few real-world evidence. To assess the impact of new therapeutic agents, we performed retrospective analysis for consecutive 158 metastatic urothelial carcin...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Yuta, Yamada, Takeshi, Fujihara, Atsuko, Miyashita, Masatsugu, Shiraishi, Takumi, Okumi, Masayoshi, Hongo, Fumiya, Ukimura, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547746/
https://www.ncbi.nlm.nih.gov/pubmed/37789182
http://dx.doi.org/10.1038/s41598-023-43901-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547746/
https://www.ncbi.nlm.nih.gov/pubmed/37789182
http://dx.doi.org/10.1038/s41598-023-43901-5

Ejemplares similares